tiprankstipranks
Advertisement

PRXV - ETF AI Analysis

Compare

Top Page

PRXV

Praxis Impact Large Cap Value ETF (PRXV)

Rating:72Outperform
Price Target:
PRXV, the Praxis Impact Large Cap Value ETF, earns a solid overall rating thanks to strong, diversified leaders like Micron, Walmart, Johnson & Johnson, and ConocoPhillips, which bring robust financial performance, positive earnings outlooks, and strategic positioning in areas like AI, healthcare, and energy. These strengths are partly offset by weaker spots such as AbbVie and Intel, where valuation and financial stability concerns weigh on their appeal, and by risks tied to individual company challenges in cash flow, leverage, and profitability rather than a single sector or region.
Positive Factors
Solid Recent Performance
The ETF has shown steady gains so far this year and over the past few months, indicating positive recent momentum.
Broad Sector Diversification
Holdings are spread across many sectors such as financials, health care, technology, and consumer stocks, which helps reduce the impact of weakness in any single industry.
Several Strong Top Holdings
Some of the largest positions, including companies in retail, technology, and energy, have delivered strong year-to-date performance that supports the fund’s returns.
Negative Factors
High U.S. Concentration
Almost all of the fund’s assets are invested in U.S. companies, offering very little geographic diversification.
Mixed Performance Among Top Holdings
A number of major positions, particularly in financials and health care, have shown weak or negative performance this year, which can drag on overall results.
Moderate Expense Ratio
The fund’s expense ratio is not especially low for a large-cap value ETF, meaning fees may be higher than some lower-cost alternatives.

PRXV vs. SPDR S&P 500 ETF (SPY)

PRXV Summary

Praxis Impact Large Cap Value ETF (PRXV) is an actively managed fund that invests mainly in large U.S. companies that appear undervalued and also meet strict environmental, social, and governance (ESG) standards. It does not track a specific index, but focuses on “value” stocks across many sectors, including financials, health care, and technology. Well-known holdings include JPMorgan Chase and Johnson & Johnson. Someone might invest in PRXV to seek long-term growth while aligning their money with their values and getting broad diversification. A key risk is that value stocks and the overall stock market can go up and down, sometimes sharply.
How much will it cost me?The Praxis Impact Large Cap Value ETF (PRXV) has an expense ratio of 0.36%, which means you’ll pay $3.60 per year for every $1,000 invested. This is slightly higher than average for ETFs because it is actively managed and focuses on socially responsible investing, which requires more research and oversight. It’s a good option if you value ethical considerations alongside financial returns.
What would affect this ETF?The PRXV ETF, with its focus on large-cap value stocks and ESG criteria, could benefit from increased investor interest in socially responsible investing and strong performance in sectors like financials and healthcare. However, it may face challenges if economic conditions weaken, particularly in North America, or if regulatory changes impact ESG-focused investments. Sector-specific risks, such as volatility in energy or technology, could also influence its future performance.

PRXV Top 10 Holdings

PRXV leans heavily into U.S. financials and other classic value names, and that’s where much of the story sits. JPMorgan and Bank of America are helping more than hurting, with their shares generally rising lately even after a softer start to the year. On the growthier side, Micron has been a real engine, riding the AI and memory boom, while Cisco adds steady tech strength. Defensive giants like Walmart are quietly lifting the fund, but consumer staples such as Procter & Gamble and pharma player AbbVie have been lagging, acting as a bit of a brake on overall returns.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Micron3.80%$2.71M$825.49B663.76%
79
Outperform
JPMorgan Chase3.37%$2.40M$809.16B15.85%
72
Outperform
Walmart2.38%$1.69M$1.04T36.40%
78
Outperform
Johnson & Johnson2.36%$1.68M$552.02B50.26%
78
Outperform
Intel2.00%$1.42M$597.89B478.88%
64
Neutral
Procter & Gamble1.86%$1.33M$331.69B-13.69%
69
Neutral
Cisco Systems1.69%$1.20M$450.70B86.55%
77
Outperform
AbbVie1.58%$1.13M$375.09B16.78%
66
Neutral
Coca-Cola1.49%$1.06M$350.87B14.10%
75
Outperform
Conocophillips1.48%$1.06M$149.07B39.96%
78
Outperform

PRXV Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
32.07
Positive
100DMA
31.84
Positive
200DMA
30.56
Positive
Market Momentum
MACD
0.28
Positive
RSI
61.92
Neutral
STOCH
66.37
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For PRXV, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 32.90, equal to the 50-day MA of 32.07, and equal to the 200-day MA of 30.56, indicating a bullish trend. The MACD of 0.28 indicates Positive momentum. The RSI at 61.92 is Neutral, neither overbought nor oversold. The STOCH value of 66.37 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for PRXV.

PRXV Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$70.81M0.36%
72
Outperform
$93.91M0.32%
73
Outperform
$90.82M0.55%
71
Outperform
$90.19M0.75%
75
Outperform
$82.85M0.50%
71
Outperform
$70.44M0.49%
73
Outperform
Performance Comparison
Ticker
Company Name
Price
Change
% Change
PRXV
Praxis Impact Large Cap Value ETF
33.28
6.63
24.88%
FLCV
Federated Hermes MDT Large Cap Value ETF
DHLX
Diamond Hill Large Cap Concentrated ETF
MAVF
Matrix Advisors Value ETF
ITAN
Sparkline Intangible Value ETF
DVAL
BrandywineGLOBAL - Dynamic US Large Cap Value ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement